Harrow (HROW) Other Non-Current Liabilities (2014 - 2024)
Harrow (HROW) recorded quarterly Other Non-Current Liabilities of $2.7 million in Q3 2024, little changed quarter-over-quarter from $2.7 million in Q2 2024, and little changed on a YoY basis from $2.7 million in Q4 2023.
Harrow (HROW) Other Non-Current Liabilities (2014 - 2024) Analysis & Trends
Harrow's Other Non-Current Liabilities history runs 10 years deep, the most recent figure standing at $2.7 million for Q3 2024.
- In Q3 2024, Other Non-Current Liabilities changed 0.0% year-over-year to $2.7 million; the TTM figure through Sep 2024 stood at $2.7 million (changed 0.0% YoY), while the FY2023 annual figure was $2.7 million, changed N/A from the prior year.
- Other Non-Current Liabilities was $2.7 million for Q3 2024 at Harrow, roughly flat from $2.7 million in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $2.7 million in Q3 2023 to a low of $800000.0 in Q1 2020.
- Historically, Other Non-Current Liabilities has averaged $1.8 million across 4 years, with a median of $2.3 million in 2023.
- The sharpest annual moves came in 2020 and 2024: Other Non-Current Liabilities changed 0.0% in 2020, then grew 19.25% in 2024.
- A 4-year view of Other Non-Current Liabilities shows it stood at $800000.0 in 2020, then changed by 0.0% to $800000.0 in 2021, then soared by 239.12% to $2.7 million in 2023, then changed by 0.0% to $2.7 million in 2024.
- The last three Other Non-Current Liabilities figures came in at $2.7 million (Q3 2024), $2.7 million (Q2 2024), and $2.7 million (Q1 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Harrow | 1.25 Bn | 1.15 Bn | 27.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 2.71 Mn |
| Jun 30, 2024 | 2.71 Mn |
| Mar 31, 2024 | 2.71 Mn |
| Dec 31, 2023 | 2.71 Mn |
| Sep 30, 2023 | 2.71 Mn |
| Jun 30, 2023 | 2.28 Mn |
| Mar 31, 2023 | 2.28 Mn |
| Mar 31, 2021 | 800,000.00 |
| Dec 31, 2020 | 800,000.00 |
| Sep 30, 2020 | 800,000.00 |
| Jun 30, 2020 | 800,000.00 |
| Mar 31, 2020 | 800,000.00 |
| Dec 31, 2019 | 800,000.00 |
| Sep 30, 2019 | 800,000.00 |
| Jun 30, 2019 | 800,000.00 |
| Mar 31, 2019 | 800,000.00 |
| Dec 31, 2018 | 800,000.00 |
| Sep 30, 2018 | 800,000.00 |
| Jun 30, 2018 | 800,000.00 |
| Mar 31, 2018 | 800,000.00 |